The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_004360.5(CDH1):c.2T>C (p.Met1Thr)

CA396451185

486826 (ClinVar)

Gene: CDH1
Condition: CDH1-related diffuse gastric and lobular breast cancer
Inheritance Mode: Autosomal dominant inheritance
UUID: 3f6e0f9d-ae4a-4d07-a4a1-4f43338d71eb
Approved on: 2023-08-25
Published on: 2023-08-25

HGVS expressions

NM_004360.5:c.2T>C
NM_004360.5(CDH1):c.2T>C (p.Met1Thr)
NC_000016.10:g.68737417T>C
CM000678.2:g.68737417T>C
NC_000016.9:g.68771320T>C
CM000678.1:g.68771320T>C
NC_000016.8:g.67328821T>C
NG_008021.1:g.5126T>C
ENST00000261769.10:c.2T>C
ENST00000261769.9:c.2T>C
ENST00000422392.6:c.2T>C
ENST00000566510.5:c.2T>C
ENST00000566612.5:c.2T>C
ENST00000611625.4:c.2T>C
ENST00000612417.4:c.2T>C
ENST00000621016.4:c.2T>C
NM_004360.3:c.2T>C
NM_001317184.1:c.2T>C
NM_001317185.1:c.-1614T>C
NM_001317186.1:c.-1818T>C
NM_004360.4:c.2T>C
NM_001317184.2:c.2T>C
NM_001317185.2:c.-1614T>C
NM_001317186.2:c.-1818T>C

Pathogenic

Met criteria codes 3
PS4_Moderate PM2_Supporting PVS1
Not Met criteria codes 23
BS2 BS4 BS3 BS1 BP2 BP4 BP1 BP3 BP5 BP7 PS2 PS3 PS1 BA1 PP4 PP1 PP3 PP2 PM3 PM1 PM5 PM4 PM6

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen CDH1 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 3.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
CDH1 VCEP
The c.2T>C (p.Met1Thr) variant alters the start codon of the CDH1 coding sequence and is predicted to lead to an absent protein (PVS1). This variant is absent in the gnomAD cohort (PM2_supporting; http://gnomad.broadinstitute.org). This variant has been reported in at least 2 probands/families meeting HDGC clinical criteria (PS4_moderate; PMID: 20373070, SCV000760804.3). In summary, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP Variant Interpretation Guidelines Version 3.1 as specified by the CDH1 Variant Curation Expert Panel: PVS1, PS4_moderate, PM2_supporting.
Met criteria codes
PS4_Moderate
Two probands/families meet HDGC phenotype criteria.
PM2_Supporting
Absent from all population databases
PVS1
PVS1 applies to initiation codon variants
Not Met criteria codes
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.